WestEnd Advisors’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349 Buy
9
+2
+29% +$105 ﹤0.01% 363
2026
Q1
$429 Hold
7
﹤0.01% 322
2025
Q4
$581 Sell
7
-2
-22% -$150 ﹤0.01% 294
2025
Q3
$604 Buy
9
+2
+29% +$145 ﹤0.01% 287
2025
Q2
$546 Hold
7
﹤0.01% 266
2025
Q1
$536 Buy
7
+5
+250% +$407 ﹤0.01% 271
2024
Q4
$154 Hold
2
﹤0.01% 286
2024
Q3
$154 Sell
2
-1
-33% -$74 ﹤0.01% 320
2024
Q2
$204 Hold
3
﹤0.01% 261
2024
Q1
$220 Hold
3
﹤0.01% 239
2023
Q4
$227 Hold
3
﹤0.01% 226
2023
Q3
$203 Buy
+3
New +$207 ﹤0.01% 227
2023
Q1
Sell
-3
Closed -$188 239
2022
Q4
$172 Sell
3
-1
-25% -$59 ﹤0.01% 240
2022
Q3
$0 Sell
4
-1
-20% -$65 ﹤0.01% 179
2022
Q2
$337 Buy
+5
New +$383 ﹤0.01% 160
2022
Q1
Sell
-3
Closed -$264 175
2021
Q4
$266 Buy
+3
New +$241 ﹤0.01% 225
2021
Q3
Hold
0
197
2021
Q2
Hold
0
244

Other funds holding CTSH

WestEnd Advisors's CTSH Position: Q2 2026 in Review

WestEnd Advisors increased its Cognizant (CTSH) stake by 29% in Q2 2026, buying an estimated $105 and bringing the position to 9 shares worth $349. The position accounts for ﹤0.01% of the portfolio, ranked #363.

WestEnd Advisors first reported a position in CTSH in Q4 2021 and has held it in 16 quarters since. The position peaked at $604 in Q3 2025. 914 funds tracked by Wall St. Rank hold CTSH as of Q2 2026.

  • WestEnd Advisors held 9 shares of Cognizant worth $349 as of Q2 2026.
  • WestEnd Advisors bought 2 Cognizant shares in Q2 2026, an estimated $105.
  • Cognizant made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #363 holding.
  • WestEnd Advisors first reported a position in Cognizant in Q4 2021 and has held it in 16 quarters since.
  • WestEnd Advisors's Cognizant position peaked at $604 in Q3 2025.
  • 914 funds tracked by Wall St. Rank held Cognizant as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.